What is the recommended treatment for Gardnerella vaginalis (bacterial vaginosis) and Mycoplasma hominis infections?

Treatment for Gardnerella vaginalis and Mycoplasma hominis

For Gardnerella vaginalis (bacterial vaginosis), treat with metronidazole 500 mg orally twice daily for 7 days; this regimen also effectively treats Mycoplasma hominis, which is part of the BV-associated microflora and responds to the same treatment.

Primary Treatment Approach

The most effective treatment for both organisms is oral metronidazole 500 mg twice daily for 7 days 1. This regimen achieves:

• 95% cure rates for bacterial vaginosis
• Eradication of G. vaginalis and M. hominis simultaneously
• Superior efficacy compared to alternative regimens

Why This Works for Both Organisms

M. hominis is consistently found as part of the BV-associated microflora alongside G. vaginalis 2, 3. When you treat BV with metronidazole or clindamycin, you simultaneously eradicate M. hominis along with other anaerobes and G. vaginalis 2. You don't need separate treatment regimens for these two organisms.

Alternative Regimens (in order of preference)

If oral metronidazole cannot be used:

1. Clindamycin 300 mg orally twice daily for 7 days 1

   • Also effective against both organisms
   • Preferred for metronidazole allergy/intolerance

2. Metronidazole gel 0.75%, one applicator (5g) intravaginally once daily for 5 days 1

   • Less systemic side effects
   • Equally efficacious to oral regimens

3. Clindamycin cream 2%, one applicator (5g) intravaginally at bedtime for 7 days 1

   • Less efficacious than metronidazole regimens
   • Oil-based; weakens latex condoms

Avoid Single-Dose Therapy

Metronidazole 2g single dose has only 84% cure rate versus 95% for the 7-day regimen 4. Use the 7-day regimen for optimal outcomes 1.

Critical Patient Counseling

• Avoid alcohol during metronidazole treatment and for 24 hours after completion 1
• No need to treat sex partners (does not improve cure rates or prevent recurrence) 1
• Recurrence is common (50-80% within one year) 5
• Return if symptoms recur for retreatment

Special Populations

Pregnancy

• All symptomatic pregnant women must be treated due to associations with preterm birth, premature rupture of membranes, and postpartum endometritis 1
• Use metronidazole 250 mg orally three times daily for 7 days 1
• Systemic therapy preferred over topical to treat possible subclinical upper tract infection
• Avoid clindamycin cream in pregnancy (associated with increased prematurity and neonatal infections) 1

Metronidazole Allergy

Use clindamycin cream or oral clindamycin 1. Patients allergic to oral metronidazole should NOT receive metronidazole gel vaginally 1.

Important Clinical Pitfalls

1. Don't assume you need different antibiotics for G. vaginalis versus M. hominis - they respond to the same BV treatment regimens

2. Don't use topical metronidazole gel for pregnancy - it doesn't treat upper tract infection and has inferior outcomes 1

3. Don't treat asymptomatic BV in low-risk pregnant women - insufficient evidence for benefit 6

4. Don't routinely treat male partners - multiple trials show no benefit 1

5. Be aware of emerging metronidazole resistance - certain G. vaginalis genospecies show high-level resistance (MIC ≥32 µg/mL) but remain clindamycin-sensitive 7

When Treatment Fails

If symptoms persist after standard therapy:

• Confirm diagnosis (consider molecular testing)
• Use alternative recommended regimen (switch between metronidazole and clindamycin)
• Consider vaginal boric acid for recurrent cases 8
• Evaluate for other causes: desquamative inflammatory vaginitis, candidiasis, trichomoniasis 8

The key insight is that M. hominis doesn't require separate consideration - it's part of the BV complex and resolves with standard BV treatment 2, 3.